Ildong Pharmaceutical challenges to KRW 100 billion market of filler

Published: 2017-01-06 14:12:15

Updated: 2017-01-06 14:12:15

Ildong Pharmaceutical(CEO Woong-Sup Yoon) released ‘Neobelle,’ hyaluronic acid filler for wrinkle improvement, and has started to pioneer its market. Based on the original technology, infrastructure and sales & marketing power related to hyaluronic acid, the company plans to make Neobelle a leading product for the next generation.

Neobelle, hyaluronic acid filler developed by Ildong Pharmaceut...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.